Skip to main navigation Skip to search Skip to main content

Evaluating the Modulatory Effects of Fingolimod (Gilenya) On The Rage Axis in Multiple Sclerosis: A Pilot Study

Project: Research

Project Details

StatusFinished
Effective start/end date06/15/12 → 10/30/16

Funding

  • Novartis Pharmaceuticals Corporation: $297,210.61